Hironao Hozumi

45PUBLICATIONS
45CO-AUTHORS
Epidemiological methodsCancer cell biologyMedical mycologyPredictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Feb 19, 2026
Clinical Characteristics and Prevalence of Apical Scarring at Chest CT in a Healthy Population.

Atsuki Fukada, Hironao Hozumi, Taiki Fukuda

|Feb 10, 2026
Cold inducible RNA binding protein promotes fibroblast activation and its inhibition represents a potential therapeutic target in pulmonary fibrosis.

Yasutaka Mochizuka, Hironao Hozumi, Hirofumi Watanabe

|Jan 23, 2026
Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD.

Yoshihiro Kitahara, Tomoyuki Fujisawa, Atsuki Fukada

|Oct 15, 2025
Survival benefit of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung diseases: a nationwide population-based study.

Masato Karayama, Koichi Miyashita, Yusuke Inoue

|Aug 14, 2025
PAI-1 Inhibitor TM5441 Attenuates Emphysema and Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease.

Kyohei Oishi, Hideki Yasui, Yusuke Inoue

|Jun 10, 2025
Prognostic value of computed tomography assessment of normal lung volume in upper lobe in idiopathic pleuroparenchymal fibroelastosis.

Yuzo Suzuki, Masato Kono, Hirotsugu Hasegawa

Pageof 8

Frequent Collaborators

31 joint publications

Tomoyuki Fujisawa

28 joint publications

Yuzo Suzuki

19 joint publications

Noriyuki Enomoto

18 joint publications

Masato Karayama